HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,798,193 | +64.8% | 352,651 | +46.5% | 0.03% | +87.5% |
| Q2 2023 | $24,757,128 | -8.8% | 240,711 | -3.2% | 0.02% | -15.8% |
| Q1 2023 | $27,153,158 | -34.1% | 248,792 | -31.3% | 0.02% | -40.6% |
| Q4 2022 | $41,206,297 | +138.8% | 362,094 | +29.9% | 0.03% | +166.7% |
| Q3 2022 | $17,256,000 | +5.9% | 278,814 | +36.5% | 0.01% | 0.0% |
| Q2 2022 | $16,292,000 | +35.1% | 204,260 | +78.1% | 0.01% | +71.4% |
| Q1 2022 | $12,063,000 | -6.7% | 114,657 | -4.4% | 0.01% | 0.0% |
| Q4 2021 | $12,928,000 | -73.2% | 119,968 | -72.8% | 0.01% | -75.0% |
| Q3 2021 | $48,324,000 | +48.1% | 441,153 | +26.6% | 0.03% | +40.0% |
| Q2 2021 | $32,622,000 | +51.5% | 348,375 | +48.9% | 0.02% | +42.9% |
| Q1 2021 | $21,528,000 | +48.5% | 233,899 | +18.1% | 0.01% | +55.6% |
| Q4 2020 | $14,493,000 | -17.5% | 198,107 | -12.4% | 0.01% | -25.0% |
| Q3 2020 | $17,566,000 | +8.2% | 226,123 | -22.6% | 0.01% | -7.7% |
| Q2 2020 | $16,232,000 | +510.7% | 292,030 | +225.3% | 0.01% | +550.0% |
| Q1 2020 | $2,658,000 | -14.4% | 89,766 | +4.6% | 0.00% | 0.0% |
| Q4 2019 | $3,106,000 | +22.8% | 85,818 | -7.6% | 0.00% | +100.0% |
| Q3 2019 | $2,529,000 | -1.2% | 92,900 | -12.7% | 0.00% | -50.0% |
| Q2 2019 | $2,561,000 | – | 106,459 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |